Prototype Pathogens for Vaccine and Monoclonal Antibody Countermeasure Development: NIAID Workshop Process and Outcomes for Viral Families of Pandemic Potential.

Deschamps, Anne M; DeRocco, Amanda J; Bok, Karin; Patterson, L Jean

Deschamps, Anne M; DeRocco, Amanda J; Bok, Karin; Patterson, L Jean.

Afiliación

Deschamps AM; Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
DeRocco AJ; Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Bok K; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Patterson LJ; Virology Branch, Translational Research Section, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

J Infect Dis ; 228(Suppl 6): S355-S358, 2023 10 18.

Article en En | MEDLINE | ID: mdl-37849398

Asunto(s)

Enfermedades Transmisibles Emergentes; Vacunas; Estados Unidos; Humanos; National Institute of Allergy and Infectious Diseases (U.S.); Pandemias/prevención & control

Palabras clave

monoclonal antibodies; pandemic preparedness; platform technologies; prototype pathogens; vaccines

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas / Enfermedades Transmisibles Emergentes País/Región como asunto: America do norte Idioma: En Revista: J Infect Dis Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google